Celestica is trading 4.59% lower at $286.03 amid broader technology weakness. - Shares fell after a two-session rally following strong quarterly results and an ambitious 2027 outlook; October 29 coverage noted the post-rally decline. - Nasdaq Composite down 1.51%; concerns include disappointing Alphabet results and AI-spending returns. - Goldman Sachs cut its target to $435 from $480, citing capital needs and expected negative 2027 free cash flow, but kept Conviction Buy; the report does not establish this as the direct cause.